Petra Van Setten
Arnhem, Gelderland, 6800 TA, Netherlands
NCT Number: NCT03105557
On a daily basis many (prematurely born) newborn are subjected to different urine collecting techniques to study biochemical abnormalities. Neonatology nurses and pediatricians are looking for a better and less invasive manner to collect urine in these vulnerable patients. We hypothesise that the urine collecting device as presented in this protocol is less invasive and has good functional abilities to collect urine in these newborns
Objective of the study:
Clinical feasibility of the urine collection device, indicated by staff and parents.
Study design:
The study will be an open label, clinical feasibility study, of the urine collection device. During a period of 6 months, 30 feasibility tests will be performed.
Study population:
Prematurely born newborns, admitted to the neonatology unit of the department of pediatrics at Rijnstate Hospital Arnhem.
Looking for future studies?
Notify MeFemale
Observational
Arnhem, Gelderland, 6800 TA, Netherlands
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Urinary collecting device
Other names: Capturin
Time frame: 1 day
With concern to feasibility we want to know whether this device is able:
Time frame: 1 week
Number of times skin reactions occurs, reported by the responsible nurse
Time frame: 1 week
Number of times skin irritability occurs, reported by the responsible nurse
Capturin Distribution B.V.
Industry
Specturi Device Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00001242
Avitaminosis, Bone Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT02548520
Avitaminosis, Bone Diseases
Aarhus, Central Jutland, Denmark
View Trial DetailsNCT02301520
Avitaminosis, Bone Diseases
Pierre Payen, Haiti
View Trial DetailsNCT00502866
Avitaminosis, Behavior
Seattle, Washington, United States
View Trial Details